Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials (Q34340824)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Hyperthermic isolated limb perfusion for extremity soft tissue sarcomas: systematic review of clinical efficacy and quality assessment of reported trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

systematic review

1 reference

based on heuristic

inferred from title

author name string

N H Trabulsi

1

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

L Patakfalvi

2

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

M O Nassif

3

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

R E Turcotte

4

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A Nichols

5

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

A N Meguerditchian

6

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

publication date

17 July 2012

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

106

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

921-928

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Comparison of amputation with limb-sparing operations for adult soft tissue sarcoma of the extremity

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Amputation for soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Effect of Definition of Mortality on Hospital Profiles

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Definitions and epidemiology

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

GNOSIS: guidelines for neuro-oncology: standards for investigational studies-reporting of phase 1 and phase 2 clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Content and quality of currently published phase II cancer trials

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Setting the bar in phase II trials: the use of historical data for determining "go/no go" decision for definitive phase III testing

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

High dose tumor necrosis factor-alpha and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results in a >90% response rate and limb preservation

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

A randomised phase II study on neo-adjuvant chemotherapy for 'high-risk' adult soft-tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Preoperative chemoradiation and flap reconstruction provide high local control and low wound complication rates for patients undergoing limb salvage surgery for upper extremity tumors

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Preoperative isolated limb infusion of Doxorubicin and external irradiation for limb-threatening soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Isolated limb perfusion for unresectable extremity sarcoma: results of 2 single-institution phase 2 trials

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Long-term results of a phase 2 study of neoadjuvant chemotherapy and radiotherapy in the management of high-risk, high-grade, soft tissue sarcomas of the extremities and body wall: Radiation Therapy Oncology Group Trial 9514.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Neoadjuvant chemoradiation therapy for soft tissue sarcomas of the extremities.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Treatment-induced pathologic necrosis: a predictor of local recurrence and survival in patients receiving neoadjuvant therapy for high-grade extremity soft tissue sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Quality of randomized controlled trials reporting in the treatment of sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Standards of reporting of randomized controlled trials in general surgery: can we do better?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

The reporting of randomized clinical trials using a surgical intervention is in need of immediate improvement: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

No surgical innovation without evaluation: the IDEAL recommendations

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Challenges in evaluating surgical innovation

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

The Delphi approach to Attain consensus in methodology of local regional therapy for peritoneal surface malignancy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Limb salvage with isolated perfusion for soft tissue sarcoma: could less TNF-alpha be better?

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Phase II study on neoadjuvant hyperthermic-antiblastic perfusion with doxorubicin in patients with intermediate or high grade limb sarcomas.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Hyperthermic isolated perfusion with low-dose TNFalpha and doxorubicin in patients with locally advanced soft tissue limb sarcomas

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Evaluation and stages of surgical innovations

1 reference

https://api.crossref.org/works/10.1002%2FJSO.23200

21 January 2018

Identifiers

10.1002/JSO.23200

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34340824&oldid=1547689278"